# tranexamic acid

### notes
+ prescription under medical supervision

### therapeutic action
+ antifibrinolytic

### indications
+ metrorrhagia (especially functional uterine bleeding) and menorrhagia

### presentation
+ 500 mg tablet

### dosage
+ adult: 3 g/day in 3 divided doses (max. 4 g/day in 4 doses) during bleeding

### duration
+ 3 to 5 days

### contra-indications, adverse effects, precautions
+ do not administer in patients with (or with history of) venous or arterial thromboembolic disease. administer with caution in the event of haematuria of renal origin (risk of anuria).
+ may cause: gastrointestinal disturbances; rarely, allergic reactions, seizures.
+ *pregnancy*: this drug is not indicated in the event of bleeding during pregnancy. 
+ *breast-feeding*: no contra-indication

### remarks
+ the treatment may given at each bleeding episode. in situations of repeated bleeding, it may be helpful to combine tranexamic acid with a non-steroidal anti-inflammatory drug (oral ibuprofen, 1200 to 2400 mg/daily maximum, to be divided in 3 doses for 3 to 5 days) and/or a long-term treatment with oral estroprogestogens or injectable progestogens.
+ storage: below 25Â°c